Symbols / QNRX Stock $5.94 +0.17% Quoin Pharmaceuticals, Ltd.
QNRX (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
- Rare-disease drugmaker Quoin sets May 7 release for Q1 results - Stock Titan hu, 30 Apr 2026 12
- QNRX stock surges 20% pre-market – what did the FDA say about Netherton syndrome lead drug? - MSN Sun, 26 Apr 2026 12
- Technical Reactions to QNRX Trends in Macro Strategies - Stock Traders Daily ue, 28 Apr 2026 21
- $QNRX stock is up 14% today. Here's what we see in our data. - Quiver Quantitative Wed, 17 Dec 2025 08
- Quoin picks PC, a no-treatment skin disease, for first QRX009 study - Stock Titan ue, 28 Apr 2026 16
- Quoin Pharmaceuticals DRC News Today (QNRX) - Investing.com Wed, 29 Apr 2026 05
- QNRX Stock Soared A Whopping 39% Today: What’s Driving The Relentless Rally? - Stocktwits ue, 11 Nov 2025 15
- Quoin Pharmaceuticals (QNRX) Stock Is Skyrocketing Friday: What's Going On? - Benzinga Fri, 10 Oct 2025 07
- (QNRX) Volatility Zones as Tactical Triggers - Stock Traders Daily Mon, 06 Apr 2026 19
- QNRX Stock Soars 300% After $104.5M Financing Through Private Placement - Stocktwits Fri, 10 Oct 2025 07
- Aberdeen Group (QNRX) reports 75,000 ADS; 4.16% stake disclosed - Stock Titan Wed, 29 Apr 2026 10
- FDA opens door to a single late-stage trial for Quoin skin drug - Stock Titan Wed, 25 Mar 2026 07
- FDA Fast Tracks lotion for rare genetic skin disorder with no approved treatment - Stock Titan Wed, 11 Mar 2026 07
- Quoin lands $104.5M as rare skin drug child study expands - Stock Titan hu, 26 Mar 2026 07
- Quoin Pharma sets March 26 update with 2025 results before market open - Stock Titan hu, 19 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
16.29
+70.97%
|
9.53
+1.60%
|
9.38
+1.30%
|
9.26
|
| Research And Development |
|
9.80
+172.10%
|
3.60
+8.91%
|
3.31
+23.76%
|
2.67
|
| Selling General And Administration |
|
6.49
+9.49%
|
5.93
-2.38%
|
6.07
-7.81%
|
6.58
|
| General And Administrative Expense |
|
6.49
+9.49%
|
5.93
-2.38%
|
6.07
-7.81%
|
6.58
|
| Other Gand A |
|
6.49
+9.49%
|
5.93
-2.38%
|
6.07
-7.81%
|
6.58
|
| Total Expenses |
|
16.29
+70.97%
|
9.53
+1.60%
|
9.38
+1.30%
|
9.26
|
| Operating Income |
|
-16.29
-70.97%
|
-9.53
-1.60%
|
-9.38
-1.30%
|
-9.26
|
| EBITDA |
|
-16.19
-71.72%
|
-9.43
-1.66%
|
-9.27
-8.31%
|
-8.56
|
| Normalized EBITDA |
|
-16.19
-71.63%
|
-9.44
-1.77%
|
-9.27
-3.25%
|
-8.98
|
| Reconciled Depreciation |
|
0.10
+0.00%
|
0.10
-3.57%
|
0.10
-0.32%
|
0.10
|
| EBIT |
|
-16.29
-70.97%
|
-9.53
-1.60%
|
-9.38
-8.20%
|
-8.67
|
| Total Unusual Items |
|
0.00
-46.95%
|
0.01
+379.61%
|
-0.00
-100.64%
|
0.42
|
| Total Unusual Items Excluding Goodwill |
|
0.00
-46.95%
|
0.01
+379.61%
|
-0.00
-100.64%
|
0.42
|
| Special Income Charges |
|
—
|
—
|
0.00
-100.00%
|
0.42
|
| Other Special Charges |
|
—
|
—
|
—
|
-0.42
|
| Net Income |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Pretax Income |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Net Non Operating Interest Income Expense |
|
0.48
-13.68%
|
0.56
-19.60%
|
0.69
+212.34%
|
-0.62
|
| Interest Expense Non Operating |
|
—
|
—
|
0.00
-100.00%
|
0.71
|
| Net Interest Income |
|
0.48
-13.68%
|
0.56
-19.60%
|
0.69
+212.34%
|
-0.62
|
| Interest Expense |
|
—
|
—
|
0.00
-100.00%
|
0.71
|
| Interest Income Non Operating |
|
0.48
-13.68%
|
0.56
-19.60%
|
0.69
+625.48%
|
0.10
|
| Interest Income |
|
0.48
-13.68%
|
0.56
-19.60%
|
0.69
+625.48%
|
0.10
|
| Other Income Expense |
|
0.00
-46.95%
|
0.01
+379.61%
|
-0.00
-100.54%
|
0.49
|
| Other Non Operating Income Expenses |
|
—
|
—
|
—
|
0.08
|
| Gain On Sale Of Security |
|
0.00
-46.95%
|
0.01
+379.61%
|
-0.00
-305.28%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Net Income From Continuing Operation Net Minority Interest |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Net Income From Continuing And Discontinued Operation |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Net Income Continuous Operations |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Normalized Income |
|
-15.81
-76.24%
|
-8.97
-3.29%
|
-8.68
+11.38%
|
-9.80
|
| Net Income Common Stockholders |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+8.05%
|
-9.45
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
0.00
-100.00%
|
0.07
|
| Diluted EPS |
|
—
|
-66.85
+80.19%
|
-337.47
+79.40%
|
-1,638.23
|
| Basic EPS |
|
—
|
-66.85
+80.19%
|
-337.47
+79.40%
|
-1,638.23
|
| Basic Average Shares |
|
—
|
0.13
+420.43%
|
0.03
+346.43%
|
0.01
|
| Diluted Average Shares |
|
—
|
0.13
+420.43%
|
0.03
+346.43%
|
0.01
|
| Diluted NI Availto Com Stockholders |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+8.05%
|
-9.45
|
| Total Other Finance Cost |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets |
|
12.17
-15.83%
|
14.46
|
—
|
| Current Assets |
|
11.29
-15.59%
|
13.37
|
—
|
| Cash Cash Equivalents And Short Term Investments |
|
10.69
-16.79%
|
12.85
|
—
|
| Cash And Cash Equivalents |
|
2.40
-16.06%
|
2.86
|
—
|
| Cash Financial |
|
—
|
2.86
-61.77%
|
7.48
|
| Other Short Term Investments |
|
8.29
-17.00%
|
9.99
|
—
|
| Prepaid Assets |
|
0.56
+8.10%
|
0.52
|
—
|
| Current Deferred Assets |
|
0.03
|
0.00
|
0.00
|
| Total Non Current Assets |
|
0.88
-18.81%
|
1.09
|
—
|
| Goodwill And Other Intangible Assets |
|
0.58
-17.21%
|
0.70
|
—
|
| Other Intangible Assets |
|
0.58
-17.21%
|
0.70
|
—
|
| Non Current Prepaid Assets |
|
0.30
-21.75%
|
0.38
|
—
|
| Other Non Current Assets |
|
—
|
—
|
0.05
|
| Total Liabilities Net Minority Interest |
|
6.51
-7.74%
|
7.05
|
—
|
| Current Liabilities |
|
3.58
+1.53%
|
3.53
|
—
|
| Payables And Accrued Expenses |
|
3.58
+1.53%
|
3.53
|
—
|
| Payables |
|
1.22
-10.60%
|
1.37
|
—
|
| Accounts Payable |
|
0.53
-13.06%
|
0.61
|
—
|
| Current Accrued Expenses |
|
2.36
+9.18%
|
2.16
|
—
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
—
|
—
|
—
|
| Total Tax Payable |
|
0.09
-41.11%
|
0.16
|
—
|
| Other Current Liabilities |
|
—
|
—
|
0.37
|
| Total Non Current Liabilities Net Minority Interest |
|
2.92
-17.03%
|
3.52
|
—
|
| Tradeand Other Payables Non Current |
|
0.00
|
0.00
|
—
|
| Stockholders Equity |
|
5.66
-23.53%
|
7.41
|
—
|
| Common Stock Equity |
|
5.66
-23.53%
|
7.41
|
—
|
| Capital Stock |
|
0.00
|
0.00
|
—
|
| Common Stock |
|
0.00
|
0.00
|
—
|
| Share Issued |
|
0.99
+144.43%
|
0.40
|
—
|
| Ordinary Shares Number |
|
0.99
+144.46%
|
0.40
|
—
|
| Treasury Shares Number |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
| Additional Paid In Capital |
|
51.87
+8.38%
|
47.86
|
—
|
| Retained Earnings |
|
-46.20
-23.15%
|
-37.52
|
—
|
| Gains Losses Not Affecting Retained Earnings |
|
—
|
—
|
—
|
| Treasury Stock |
|
0.00
-100.00%
|
2.93
+0.00%
|
2.93
|
| Other Equity Adjustments |
|
—
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
5.66
-23.53%
|
7.41
|
—
|
| Total Capitalization |
|
5.66
-23.53%
|
7.41
|
—
|
| Working Capital |
|
7.70
-21.72%
|
9.84
|
—
|
| Invested Capital |
|
5.66
-23.53%
|
7.41
|
—
|
| Net Tangible Assets |
|
5.08
-24.19%
|
6.70
|
—
|
| Tangible Book Value |
|
5.08
-24.19%
|
6.70
|
—
|
| Dueto Related Parties Current |
|
0.60
+0.00%
|
0.60
|
—
|
| Dueto Related Parties Non Current |
|
2.92
-17.03%
|
3.52
|
—
|
| Interest Payable |
|
1.15
+0.00%
|
1.15
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-13.54
-72.34%
|
-7.86
+0.09%
|
-7.86
+7.27%
|
-8.48
|
| Cash Flow From Continuing Operating Activities |
|
-13.54
-72.34%
|
-7.86
+0.09%
|
-7.86
+7.27%
|
-8.48
|
| Net Income From Continuing Operations |
|
-15.80
-76.34%
|
-8.96
-3.18%
|
-8.69
+7.41%
|
-9.38
|
| Depreciation Amortization Depletion |
|
0.10
+0.00%
|
0.10
-3.57%
|
0.10
-0.32%
|
0.10
|
| Amortization Cash Flow |
|
0.10
+0.00%
|
0.10
-3.57%
|
0.10
-0.32%
|
0.10
|
| Depreciation And Amortization |
|
0.10
+0.00%
|
0.10
-3.57%
|
0.10
-0.32%
|
0.10
|
| Amortization Of Intangibles |
|
0.10
+0.00%
|
0.10
-3.57%
|
0.10
-0.32%
|
0.10
|
| Other Non Cash Items |
|
—
|
—
|
—
|
0.71
|
| Stock Based Compensation |
|
1.15
-8.87%
|
1.26
+15.01%
|
1.09
+43.26%
|
0.76
|
| Asset Impairment Charge |
|
—
|
0.00
-100.00%
|
0.02
|
0.00
|
| Operating Gains Losses |
|
—
|
—
|
—
|
-0.49
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
-0.08
|
| Unrealized Gain Loss On Investment Securities |
|
-0.22
+14.20%
|
-0.25
+48.56%
|
-0.49
-421.52%
|
-0.09
|
| Change In Working Capital |
|
1.23
+57764.01%
|
-0.00
-102.24%
|
0.10
+201.16%
|
-0.09
|
| Change In Prepaid Assets |
|
-0.09
+66.61%
|
-0.28
-769.73%
|
0.04
-66.37%
|
0.12
|
| Change In Payables And Accrued Expense |
|
1.33
+380.20%
|
0.28
+411.75%
|
0.05
+124.76%
|
-0.22
|
| Change In Accrued Expense |
|
—
|
—
|
—
|
—
|
| Change In Payable |
|
1.33
+380.20%
|
0.28
+411.75%
|
0.05
+124.76%
|
-0.22
|
| Change In Account Payable |
|
1.33
+380.20%
|
0.28
+411.75%
|
0.05
+124.76%
|
-0.22
|
| Investing Cash Flow |
|
-4.28
-126.54%
|
-1.89
-186.29%
|
2.19
+121.56%
|
-10.15
|
| Cash Flow From Continuing Investing Activities |
|
-4.28
-126.54%
|
-1.89
-186.29%
|
2.19
+121.56%
|
-10.15
|
| Capital Expenditure |
|
—
|
—
|
—
|
-0.25
|
| Net Investment Purchase And Sale |
|
-4.28
-126.54%
|
-1.89
-186.29%
|
2.19
+122.11%
|
-9.90
|
| Purchase Of Investment |
|
-12.26
+28.92%
|
-17.25
+4.62%
|
-18.09
-82.75%
|
-9.90
|
| Sale Of Investment |
|
7.99
-48.03%
|
15.37
-24.23%
|
20.28
|
0.00
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-0.25
|
| Purchase Of Intangibles |
|
—
|
—
|
0.00
+100.00%
|
-0.25
|
| Financing Cash Flow |
|
18.01
+64.25%
|
10.97
+110.24%
|
5.22
-62.76%
|
14.01
|
| Cash Flow From Continuing Financing Activities |
|
18.01
+64.25%
|
10.97
+110.24%
|
5.22
-62.76%
|
14.01
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-0.31
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-0.31
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Short Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-0.31
|
| Net Short Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-0.31
|
| Net Other Financing Charges |
|
18.01
+64.25%
|
10.97
+110.24%
|
5.22
-63.57%
|
14.32
|
| Changes In Cash |
|
0.20
-84.01%
|
1.22
+366.01%
|
-0.46
+90.06%
|
-4.62
|
| Effect Of Exchange Rate Changes |
|
-0.00
|
0.00
|
—
|
—
|
| Beginning Cash Position |
|
3.62
+50.90%
|
2.40
-16.06%
|
2.86
-61.77%
|
7.48
|
| End Cash Position |
|
3.82
+5.37%
|
3.62
+50.90%
|
2.40
-16.06%
|
2.86
|
| Free Cash Flow |
|
-13.54
-72.34%
|
-7.86
+0.09%
|
-7.86
+9.92%
|
-8.73
|
| Interest Paid Supplemental Data |
|
—
|
—
|
—
|
0.00
|
| Change In Interest Payable |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-31 View
- 10-K2026-03-26 View
- 8-K2026-03-26 View
- 8-K2026-03-11 View
- 42026-02-06 View
- 42026-02-06 View
- 42026-02-06 View
- 42026-02-06 View
- 42026-02-06 View
- 42026-02-06 View
- 42026-02-06 View
- 42026-02-06 View
- 8-K2026-01-20 View
- 42025-12-03 View
- 8-K2025-11-17 View
- 8-K2025-11-12 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 8-K2025-10-21 View
- 42025-10-15 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|